Evidence map›Paper›PMID 38499763›Full record

ArticleNature metabolism2024

Activation of GPR81 by lactate drives tumour-induced cachexia.

Xidan Liu, Shijin Li, Qionghua Cui, Bujing Guo, Wanqiu Ding, Jie Liu, Li Quan, Xiaochuan Li, Peng Xie, Li Jin and 10 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
30.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Promoting Treg Polarization-Mediated Anti-Scar and Appendage Regeneration in Wound Healing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  15. FNDC1 Competitively Binds Gβ2 to Suppress the β-Catenin-Destruction Complex and Promote Gastric Cancer Malignancy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  16. Article
  17. Review
  18. Glycolysis enzymes and cellular lactylation in tumour.Clinical and translational medicine · 2026
    Review
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Xidan Liu *Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-7131-8452
Shijin Li *Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-8519-9175
Qionghua Cui *Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-5285-5260
Bujing GuoInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Wanqiu DingInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0002-6650-8662
Jie LiuDazhou Central Hospital, Sichuan, China.
Li QuanInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Xiaochuan LiInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Peng XieInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Li JinInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Ye ShengInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0009-0008-2958-6953
Wenxin ChenInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0003-3193-6736
Kai WangPeking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
Fanxin ZengDazhou Central Hospital, Sichuan, China.
Yifu QiuInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-5645-3189
Changlu LiuSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Yan ZhangInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0002-8322-467X
Fengxiang LvInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID http://orcid.org/0000-0002-9535-1326
Xinli HuInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China. huxxx025@pku.edu.cn.ORCID http://orcid.org/0000-0003-4911-5354
Rui-Ping XiaoInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China. xiaor@pku.edu.cn.ORCID http://orcid.org/0000-0003-2448-409X
Peking University · CNDazhou Central Hospital · CNSanford Burnham Prebys Medical Discovery Institute · US

Funding

Beijing Municipal Science and Technology Commission Z171100000417006Chinese Ministry of Science and Technology | Department of S and T for Social Development (Department of S&T for Social Development) 2018YFA0800701Chinese Ministry of Science and Technology | Department of S and T for Social Development (Department of S&T for Social Development) 2022YFA1303000National Natural Science Foundation of China (National Science Foundation of China) 81630008 and 81790621National Natural Science Foundation of China (National Science Foundation of China) 81770376Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) 5182010
6 · The paper itself

Abstract

Cachexia affects 50-80% of patients with cancer and accounts for 20% of cancer-related death, but the underlying mechanism driving cachexia remains elusive. Here we show that circulating lactate levels positively correlate with the degree of body weight loss in male and female patients suffering from cancer cachexia, as well as in clinically relevant mouse models. Lactate infusion per se is sufficient to trigger a cachectic phenotype in tumour-free mice in a dose-dependent manner. Furthermore, we demonstrate that adipose-specific G-protein-coupled receptor (GPR)81 ablation, similarly to global GPR81 deficiency, ameliorates lactate-induced or tumour-induced adipose and muscle wasting in male mice, revealing adipose GPR81 as the major mediator of the catabolic effects of lactate. Mechanistically, lactate/GPR81-induced cachexia occurs independently of the well-established protein kinase A catabolic pathway, but it is mediated by a signalling cascade sequentially activating Gi-Gβγ-RhoA/ROCK1-p38. These findings highlight the therapeutic potential of targeting GPR81 for the treatment of this life-threatening complication of cancer.

Indexed as

CachexiaLactic AcidNeoplasmsReceptors, G-Protein-CoupledAnimalsFemaleHumansMaleMiceSignal TransductionHCAR1 protein, humanHcar1 protein, mouseLactic AcidReceptors, G-Protein-Coupled

Identifiers

PMID38499763
PMCPMC11052724
OpenAlexW4392906950

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.